RxAssist Home
RxAssist Home Home  I  About Us  I  Contact RxAssist          
      Patient Assistance Program Center
 

  
Patient Assistance Program Eligibility Criteria and Medicare Part D

Will your Medicare patients be eligible for Patient Assistance Programs?
Updates are made as they are received. Last updated September 5, 2008.

No Medicare Patients may apply for PAPs

Actelion

American Regent

Axcan

Biogen

Boehringer Ingleheim

Cangene

Cephalon
Dermik

Eisai (Part D see below)

IVAX

MedImmune

Millenium

Mylan
Purdue
Reliant

Salix

Savient

Sciele Pharma

Scios

Teva/Gate

Watson

Medicare Patients without a Part D plan may apply for PAPs

Alpharma

Amgen (Part D see below)

Amylin

Astellas Pharma (Part D see below)

Bayer

Berlex

Biovail

Bradley Pharmaceuticals
Centocor

Daiichi Sankyo

Duramed

Eli Lilly (Part D see below)

Endo

Enzon

ESP

Forest

Galderma

Genentech

Genzyme (Part D see below)

Graceway

Intermune

King

MedPointe

MGI
NitroMed

Novo-Nordisk

Ortho-Biotech (Part D see below)

PDL Biopharm

Reckett Benckiser

Roche (Part D see below)

Serono

Shire (Part D see below)

Solvay

TAP (Part D see below)

Upsher-Smith

Valeant (Part D see below)
Vistakon

All Medicare Patients may apply for PAPs

Abbott *

Alcon (Part D enrollees must submit a hardship letter)

Allergan*

AstraZeneca-Part D enrollees use AZ Medicines & Me
Bristol Myer Squibb*

Berlex/Beta Seron Fnd. (Cannot be LIS eligible)

Celgene

Chiron/TOBI - Part D enrollees may be eligible for product or co-pay assistance

Digestive Care

Eytech

Gilead*

GlaxoSmithKline-Part D enrollees use GSK Access program

Johnson & Johnson*

Kos

Merck*

Merck/Schering Plough *

NABI (Cannot be LIS eligible) Novartis

Pfizer* (Some medications may not be available to Part D enrollees)

Procter & Gamble (Cannot be LIS eligible)

Sanofi-Aventis (Appeal process for Medicare enrolled, financially-needed patients who have a life threatening condition confirmed by physician)

Schering-Plough

Takeda*

UCB
Wyeth (Part D enrollees must submit a hardship letter or LIS denial letter)

Amgen- Sensipar and Enbrel only

Astellas Pharma - Prograf only

Eisai - Aricept only

Eli Lilly - Zyprexa, Forteo and Humatrope only through LillyMedicareAnswers

Genzyme - Renagel only through Renagel Part D PAP

Ligand--only if drugs not in patient’s Part D plan

Ortho-Biotech - Only if drugs not in patient's Part D plan

Roche - Only if drugs not in patient's Part D plan

Shire - Fosrenol, only if drug not in patient's Part D plan

TAP - Prevacid Only

Valeant - Only if drugs not in patient's Part D plan; Part D enrollees ineligible for Infergen PAP

LIS = Low-Income Subsidy within Part D
*Will consider consider allowing some Part D enrollees to apply for PAPs; contact the company for more information.

If you should have additional information about a pharmaceutical company's response to Medicare Part D and its PAP, please contact us.

 

 

 
Copyright © 1999-2006, Volunteers in Health Care, all rights reserved. Web design by Human Service Solutions and Programming by William Kelley Consulting